MovDisordV3, Main, Merge, bibRecord, 009179

Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa

Identifieur interne : 009179 ( Main/Merge ); précédent : 009178; suivant : 009180

Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa

Auteurs : M. Guttman [Canada] ; G. Leger ; A. Reches ; A. Evans ; H. Kuwabara ; J. M. Cedarbaum ; A. Gjedde

Source :

Movement disorders [ 0885-3185 ] ; 1993.

RBID : Pascal:93-0595134

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Traitement, Animal, Chimiothérapie, Antiparkinsonien, Catechol methyltransferase, Inhibiteur, Singe, Association médicamenteuse, OR-611.
Wicri :
- topic : Singe.

English descriptors

KwdEn :
- Animal, Antiparkinson agent, Catechol methyltransferase, Chemotherapy, Drug combination, Inhibitor, Monkey, Parkinson disease, Treatment.

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 003714
to stream PascalFrancis, to step Curation: 003110
to stream PascalFrancis, to step Checkpoint: 003759

Links to Exploration step

Pascal:93-0595134

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa</title>
<author><name sortKey="Guttman, M" sort="Guttman, M" uniqKey="Guttman M" first="M." last="Guttman">M. Guttman</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>McGill univ., Montreal neurological inst., dep. neurology neurosurgery</s1>
<s2>Montreal PQ H3A 2B4</s2>
<s3>CAN</s3>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal PQ H3A 2B4</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Leger, G" sort="Leger, G" uniqKey="Leger G" first="G." last="Leger">G. Leger</name>
</author>
<author><name sortKey="Reches, A" sort="Reches, A" uniqKey="Reches A" first="A." last="Reches">A. Reches</name>
</author>
<author><name sortKey="Evans, A" sort="Evans, A" uniqKey="Evans A" first="A." last="Evans">A. Evans</name>
</author>
<author><name sortKey="Kuwabara, H" sort="Kuwabara, H" uniqKey="Kuwabara H" first="H." last="Kuwabara">H. Kuwabara</name>
</author>
<author><name sortKey="Cedarbaum, J M" sort="Cedarbaum, J M" uniqKey="Cedarbaum J" first="J. M." last="Cedarbaum">J. M. Cedarbaum</name>
</author>
<author><name sortKey="Gjedde, A" sort="Gjedde, A" uniqKey="Gjedde A" first="A." last="Gjedde">A. Gjedde</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">93-0595134</idno>
<date when="1993">1993</date>
<idno type="stanalyst">PASCAL 93-0595134 INIST</idno>
<idno type="RBID">Pascal:93-0595134</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003714</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003110</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">003759</idno>
<idno type="wicri:doubleKey">0885-3185:1993:Guttman M:administration:of:the</idno>
<idno type="wicri:Area/Main/Merge">009179</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa</title>
<author><name sortKey="Guttman, M" sort="Guttman, M" uniqKey="Guttman M" first="M." last="Guttman">M. Guttman</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>McGill univ., Montreal neurological inst., dep. neurology neurosurgery</s1>
<s2>Montreal PQ H3A 2B4</s2>
<s3>CAN</s3>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal PQ H3A 2B4</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Leger, G" sort="Leger, G" uniqKey="Leger G" first="G." last="Leger">G. Leger</name>
</author>
<author><name sortKey="Reches, A" sort="Reches, A" uniqKey="Reches A" first="A." last="Reches">A. Reches</name>
</author>
<author><name sortKey="Evans, A" sort="Evans, A" uniqKey="Evans A" first="A." last="Evans">A. Evans</name>
</author>
<author><name sortKey="Kuwabara, H" sort="Kuwabara, H" uniqKey="Kuwabara H" first="H." last="Kuwabara">H. Kuwabara</name>
</author>
<author><name sortKey="Cedarbaum, J M" sort="Cedarbaum, J M" uniqKey="Cedarbaum J" first="J. M." last="Cedarbaum">J. M. Cedarbaum</name>
</author>
<author><name sortKey="Gjedde, A" sort="Gjedde, A" uniqKey="Gjedde A" first="A." last="Gjedde">A. Gjedde</name>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1993">1993</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animal</term>
<term>Antiparkinson agent</term>
<term>Catechol methyltransferase</term>
<term>Chemotherapy</term>
<term>Drug combination</term>
<term>Inhibitor</term>
<term>Monkey</term>
<term>Parkinson disease</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Traitement</term>
<term>Animal</term>
<term>Chimiothérapie</term>
<term>Antiparkinsonien</term>
<term>Catechol methyltransferase</term>
<term>Inhibiteur</term>
<term>Singe</term>
<term>Association médicamenteuse</term>
<term>OR-611</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Singe</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><noCountry><name sortKey="Cedarbaum, J M" sort="Cedarbaum, J M" uniqKey="Cedarbaum J" first="J. M." last="Cedarbaum">J. M. Cedarbaum</name>
<name sortKey="Evans, A" sort="Evans, A" uniqKey="Evans A" first="A." last="Evans">A. Evans</name>
<name sortKey="Gjedde, A" sort="Gjedde, A" uniqKey="Gjedde A" first="A." last="Gjedde">A. Gjedde</name>
<name sortKey="Kuwabara, H" sort="Kuwabara, H" uniqKey="Kuwabara H" first="H." last="Kuwabara">H. Kuwabara</name>
<name sortKey="Leger, G" sort="Leger, G" uniqKey="Leger G" first="G." last="Leger">G. Leger</name>
<name sortKey="Reches, A" sort="Reches, A" uniqKey="Reches A" first="A." last="Reches">A. Reches</name>
</noCountry>
<country name="Canada"><noRegion><name sortKey="Guttman, M" sort="Guttman, M" uniqKey="Guttman M" first="M." last="Guttman">M. Guttman</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 009179 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 009179 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     Pascal:93-0595134
   |texte=   Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa

Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri